IFC invests $30m in Indian vaccine maker Biological E for future Covid vaccines, routine immunisation

IFC said its financing will help increase production of vaccines and, thus, competitiveness of the vaccine market geared toward the developing world, pushing other manufacturers to lower their prices when selling through international groups like Gavi and UNICEF to support country-led immunizations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2WrDBzu
via IFTTT